Bausch Health Cos. Inc. (BHC)

21.33
NYSE : Health Technology
Prev Close 22.10
Day Low/High 21.25 / 22.13
52 Wk Low/High 17.20 / 28.45
Avg Volume 3.26M
Exchange NYSE
Shares Outstanding 352.27M
Market Cap 7.79B
EPS -11.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Bausch Health Companies Inc. Announces Second-Quarter 2019 Results And Raises Full-Year Guidance

Bausch Health Companies Inc. Announces Second-Quarter 2019 Results And Raises Full-Year Guidance

LAVAL, Quebec , Aug. 6, 2019 /PRNewswire/ -- Second-Quarter 2019 Financial Results Revenues of $2.

Dow Rebound?, Disney Reports, Barneys Files Chapter 11 - 5 Things You Must Know

Dow Rebound?, Disney Reports, Barneys Files Chapter 11 - 5 Things You Must Know

U.S. stock futures rise Tuesday, following Wall Street's worst day of the year, as China attempts to ease trade tensions with the U.S., Walt Disney to report earnings Tuesday; Barneys New York files for bankruptcy protection.

Bausch Health Expands Dermatology Cash-Pay Prescription Program To Walgreens Stores Nationwide

Bausch Health Expands Dermatology Cash-Pay Prescription Program To Walgreens Stores Nationwide

Dermatology.com Supports Lower, Predictable Pricing for Many of Bausch Health's Prescription Dermatology Products at Walgreens 9,500 Retail Pharmacies DEERFIELD, Ill.

Bausch Health To Reduce Debt By Additional $100 Million Using Cash Flow From Operations

Bausch Health To Reduce Debt By Additional $100 Million Using Cash Flow From Operations

LAVAL, Quebec, July 29, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it put in notice to pay down an additional $100 million of its senior secured term loans this week, using cash...

Bausch Lomb Announces U.S. Launch Of Ocuvite® Eye Performance Vitamins

Bausch Lomb Announces U.S. Launch Of Ocuvite® Eye Performance Vitamins

Now Available at Major U.S.

Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6

Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6

LAVAL, Quebec, July 8, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2019 financial results on Tuesday, Aug.

Bausch Health Gains on Debt Reduction, Psoriasis-Lotion Launch

Bausch Health Gains on Debt Reduction, Psoriasis-Lotion Launch

Bausch Health gain after key reduction in debt and rollout of new psoriasis treatment lotion.

Bausch Health To Reduce Debt By Additional $100 Million Using Cash Generated From Operations

Bausch Health To Reduce Debt By Additional $100 Million Using Cash Generated From Operations

LAVAL, Quebec, June 25, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it put in notice to pay down an additional $100 million of its senior secured term loans this week, using cash...

HP, Mercadolibre, Bausch Health: 'Mad Money' Lightning Round

HP, Mercadolibre, Bausch Health: 'Mad Money' Lightning Round

Jim Cramer takes a look at HP, Mercadolibre, Bausch Health, ArcelorMittal, Johnson & Johnson, Transdigm Group, PPL Corp. McKesson and more.

Bausch Lomb ULTRA® Multifocal For Astigmatism Contact Lenses Now Available In The United States

Bausch Lomb ULTRA® Multifocal For Astigmatism Contact Lenses Now Available In The United States

New Lens is the Most Advanced Soft Contact Lens Design in Bausch + Lomb History Only Multifocal Toric Lens that Offers Eye Care Professionals a Convenient Same-Day Fit to Address Patients with Astigmatism and Presbyopia BRIDGEWATER, N.

Bausch Health Companies Announces Participation In Upcoming Investor Conferences

Bausch Health Companies Announces Participation In Upcoming Investor Conferences

LAVAL, Quebec, May 29, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in two investor conferences in June.

Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes

Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes

LAVAL, Quebec, May 23, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today the results to date of its pending cash tender offers (collectively, the "Tender Offers," and each...

Bausch Health: Long-Term Promise or Stalled at the Top of the Range?

Bausch Health: Long-Term Promise or Stalled at the Top of the Range?

Shares of BHC are up 41% for the year, but we need to be forward looking and check out the charts too.

Can't Keep the Winners Down: Cramer's 'Mad Money' Recap (Thursday 5/9/19)

Can't Keep the Winners Down: Cramer's 'Mad Money' Recap (Thursday 5/9/19)

Jim Cramer says that sometimes it takes a really bad day to reveal the true winning stocks.

Bausch Health Announces Pricing Of Private Offering Of Senior Notes

Bausch Health Announces Pricing Of Private Offering Of Senior Notes

LAVAL, Quebec, May 9, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced its previously announced offering of $750,000,000 aggregate principal amount of 7.

Bausch Health Commences Cash Tender Offers For Up To $1,500,000,000 Aggregate Principal Amount Of Outstanding Notes Of Certain Series

Bausch Health Commences Cash Tender Offers For Up To $1,500,000,000 Aggregate Principal Amount Of Outstanding Notes Of Certain Series

LAVAL, Quebec, May 9, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today that it has commenced cash tender offers (collectively, the "Tender Offers," and each offer to purchase...

Bausch Health Announces Launch Of Private Offering Of Senior Notes

Bausch Health Announces Launch Of Private Offering Of Senior Notes

LAVAL, Quebec, May 9, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of $750,000,000 aggregate principal amount of senior notes due 2028 (the "2028...

Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance

Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance

LAVAL, Quebec, May 6, 2019 /PRNewswire/ -- First-Quarter 2019 Financial Results Revenues of $2.

Trump's Tariff Threat, Warren Buffett, Anadarko, Boeing - 5 Things You Must Know

Trump's Tariff Threat, Warren Buffett, Anadarko, Boeing - 5 Things You Must Know

U.S. stock futures fall sharply after Donald Trump, in a surprise move, says tariffs on $200 billion worth of China-made goods would rise to 25% from 10% by Friday, just days after saying negotiations were 'going very well' between the world's two biggest economies; Occidental Petroleum revises its $57 billion offer to buy Anadarko Petroleum, adding more cash to its offer as it tries to push aside Chevron in a bidding war.

Is Elon Musk Mortgaging Tesla Shares Against a Potential Margin Call?

Is Elon Musk Mortgaging Tesla Shares Against a Potential Margin Call?

Short-sellers are pointing to a big risk for Tesla investors and an opportunity for traders.

Bausch Health Issues Form 8K For 2019 Annual Meeting Of Shareholders Presentation

Bausch Health Issues Form 8K For 2019 Annual Meeting Of Shareholders Presentation

LAVAL, Quebec, April 30, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced Bausch Health Companies Inc.

New Scientific And Clinical Analyses Regarding Bausch Lomb Surgical And Pharmaceutical Products To Be Presented During The Association For Research In Vision And Ophthalmology Meeting

New Scientific And Clinical Analyses Regarding Bausch Lomb Surgical And Pharmaceutical Products To Be Presented During The Association For Research In Vision And Ophthalmology Meeting

Data from the Company's Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study will also be Featured BRIDGEWATER, N.

IIROC Trade Resumption - BHC

IIROC Trade Resumption - BHC

TORONTO, April 25, 2019 /CNW/ - Trading resumes in: Company: Bausch Health Companies Inc.

IIROC Trading Halt - BHC

IIROC Trading Halt - BHC

TORONTO, April 25, 2019 /CNW/ - The following issues have been halted by IIROC: Company: Bausch Health Companies Inc.

TheStreet Quant Rating: D+ (Sell)